MLAB
Price
$129.10
Change
-$0.10 (-0.08%)
Updated
Oct 22 closing price
Capitalization
722.43M
14 days until earnings call
Intraday BUY SELL Signals
VNT
Price
$34.55
Change
+$0.40 (+1.17%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
4.62B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLAB vs VNT

MLAB vs VNT Comparison Chart in %
View a ticker or compare two or three
VS
MLAB vs. VNT commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLAB is a Hold and VNT is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MLAB with price predictions
Oct 22, 2026

MLAB in upward trend: price rose above 50-day moving average on October 21, 2026

MLAB moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 70 cases where MLAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on MLAB as a result. In 64 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

Following a +4.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where MLAB advanced for three days, in 225 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 135 of 195 cases where MLAB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Bearish Trend Analysis

The 10-day RSI Indicator for MLAB moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 25 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.

The Moving Average Convergence Divergence Histogram (MACD) for MLAB turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 41 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

MLAB broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. MLAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.827) is normal, around the industry mean (1.599). MLAB has a moderately high P/E Ratio (151.882) as compared to the industry average of (7.243). Projected Growth (PEG Ratio) (1.390) is also within normal values, averaging (5.470). Dividend Yield (0.005) settles around the average of (0.011) among similar stocks. P/S Ratio (2.818) is also within normal values, averaging (32.028).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for VNT with price predictions
Oct 22, 2026

VNT in upward trend: price rose above 50-day moving average on October 15, 2026

VNT moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 23 of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on VNT as a result. In 58 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

The Moving Average Convergence Divergence (MACD) for VNT just turned positive on October 01, 2026. Looking at past instances where VNT's MACD turned positive, the stock continued to rise in 30 of 42 cases over the following month. The odds of a continued upward trend are 71%.

The 10-day moving average for VNT crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Following a +1.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where VNT advanced for three days, in 213 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

The Aroon Indicator entered an Uptrend today. In 187 of 292 cases where VNT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

VNT broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. VNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.871) is normal, around the industry mean (1.599). P/E Ratio (14.112) is within average values for comparable stocks, (7.243). Projected Growth (PEG Ratio) (0.758) is also within normal values, averaging (5.470). Dividend Yield (0.003) settles around the average of (0.011) among similar stocks. P/S Ratio (1.476) is also within normal values, averaging (32.028).

The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 98 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
MLAB vs VNT: Fundamental Ratings
MLAB
VNT
OUTLOOK RATING
1..100
1011
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
8835
PRICE GROWTH RATING
1..100
3847
P/E GROWTH RATING
1..100
2558
SEASONALITY SCORE
1..100
n/a17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VNT's Valuation (55) in the null industry is somewhat better than the same rating for MLAB (90) in the Medical Specialties industry. This means that VNT’s stock grew somewhat faster than MLAB’s over the last 12 months.

VNT's Profit vs Risk Rating (98) in the null industry is in the same range as MLAB (100) in the Medical Specialties industry. This means that VNT’s stock grew similarly to MLAB’s over the last 12 months.

VNT's SMR Rating (35) in the null industry is somewhat better than the same rating for MLAB (88) in the Medical Specialties industry. This means that VNT’s stock grew somewhat faster than MLAB’s over the last 12 months.

MLAB's Price Growth Rating (38) in the Medical Specialties industry is in the same range as VNT (47) in the null industry. This means that MLAB’s stock grew similarly to VNT’s over the last 12 months.

MLAB's P/E Growth Rating (25) in the Medical Specialties industry is somewhat better than the same rating for VNT (58) in the null industry. This means that MLAB’s stock grew somewhat faster than VNT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MLABVNT
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
31%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
56%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 1 day ago
66%
Declines
ODDS (%)
Bearish Trend 9 days ago
78%
Bearish Trend 15 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
47%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
64%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (MLAB: $129.20 vs. VNT: $34.15)
Brand notoriety: MLAB and VNT are both not notable
Both companies represent the Electronic Equipment/Instruments industry
Current volume relative to the 65-day Moving Average: MLAB: 56% vs. VNT: 90%
Market capitalization -- MLAB: $722.43M vs. VNT: $4.62B
MLAB [@Electronic Equipment/Instruments] is valued at $722.43M. VNT’s [@Electronic Equipment/Instruments] market capitalization is $4.62B. The market cap for tickers in the [@Electronic Equipment/Instruments] industry ranges from $12.56K to $120.89B. The average market capitalization across the [@Electronic Equipment/Instruments] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLAB’s FA Score shows that 1 FA rating(s) are green while VNT’s FA Score has 0 green FA rating(s).

  • MLAB’s FA Score: 1 green, 4 red.
  • VNT’s FA Score: 0 green, 5 red.
According to our system of comparison, VNT is a better buy in the long-term than MLAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLAB’s TA Score shows that 4 TA indicator(s) are bullish while VNT’s TA Score has 5 bullish TA indicator(s).

  • MLAB’s TA Score: 4 bullish, 5 bearish.
  • VNT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VNT is a better buy in the short-term than MLAB.

Price Growth

MLAB (@Electronic Equipment/Instruments) experienced а +2.41% price change this week, while VNT (@Electronic Equipment/Instruments) price change was +5.34% for the same time period.

The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -3.39%. For the same industry, the average monthly price growth was -13.90%, and the average quarterly price growth was -16.41%.

Reported Earning Dates

MLAB is expected to report earnings on Nov 05, 2026.

VNT is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Electronic Equipment/Instruments (-3.39% weekly)

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

View a ticker or compare two or three
MLAB
Daily Signal:
Gain/Loss:
VNT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

MLAB and

Correlation & Price change

A.I.dvisor tells us that MLAB and BKSY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLAB and BKSY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLAB
1D Price
Change %
MLAB100%
-0.08%
BKSY - MLAB
27%
Poorly correlated
-3.80%
TRMB - MLAB
25%
Poorly correlated
+2.27%
ITRI - MLAB
25%
Poorly correlated
+3.72%
FTV - MLAB
23%
Poorly correlated
+2.40%
VNT - MLAB
23%
Poorly correlated
+1.14%
More

VNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNT has been loosely correlated with ITRI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VNT jumps, then ITRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNT
1D Price
Change %
VNT100%
+1.14%
ITRI - VNT
49%
Loosely correlated
+3.72%
TRMB - VNT
43%
Loosely correlated
+2.27%
ST - VNT
42%
Loosely correlated
-3.74%
TDY - VNT
40%
Loosely correlated
-1.53%
BKSY - VNT
39%
Loosely correlated
-3.80%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVR6110.63210.63
+3.57%
NVR
BWMX15.980.09
+0.57%
Betterware de Mexico SAPI de CV
IMAX52.31-0.78
-1.47%
Imax Corp
GHG0.99-0.03
-2.68%
GreenTree Hospitality Group Ltd
APUS3.16-0.09
-2.77%
Apimeds Pharmaceuticals US Inc.